Breaking James Harden’s Gun Charge Dismissed in Texas After Program Completion Geno Smith Appears in Prime Condition, Says Jets Offensive Coordinator Frank Reich Stefon Diggs Returns to Maryland Roots, Joins Commanders Buffalo Bills Secure O’Cyrus Torrence with Four-Year Contract Extension Moroccan Taxi Drivers Sentenced for Aiding Irregular Migration to Ceuta

Friday August 7, 2026

Reporter

Beam Therapeutics

2Articles Published

5Communities Covered

Published Articles

Press Release

Beam Therapeutics Reports Second Quarter 2026 Financial Results and Announces First Patient Dosed in Global Pivotal Cohort of BEAM-302 Trial in Alpha-1 Antitrypsin Deficiency (AATD)

Aug 4

Press Release

Beam Therapeutics to Present Updated Data from Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) in Late-Breaking Oral Presentation at the European Respiratory Society (ERS) Congress 2026

Jul 23